APA

Foglietta M., Neelapu S. S., Kwak L. W., Jiang Y., Nattamai D., Lee S., Fowler D. H., Sportes C., Gress R. E., Steinberg S. M., Vence L. M., Radvanyi L., Dwyer K. C., Qazilbash M. H., Bryant R. N. K. & Bishop M. R. (20131211). Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients. : Bone marrow transplantation.

Chicago

Foglietta M, Neelapu S S, Kwak L W, Jiang Y, Nattamai D, Lee S-T, Fowler D H, Sportes C, Gress R E, Steinberg S M, Vence L M, Radvanyi L, Dwyer K C, Qazilbash M H, Bryant R N K and Bishop M R. 20131211. Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients. : Bone marrow transplantation.

Harvard

Foglietta M., Neelapu S. S., Kwak L. W., Jiang Y., Nattamai D., Lee S., Fowler D. H., Sportes C., Gress R. E., Steinberg S. M., Vence L. M., Radvanyi L., Dwyer K. C., Qazilbash M. H., Bryant R. N. K. and Bishop M. R. (20131211). Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients. : Bone marrow transplantation.

MLA

Foglietta M, Neelapu S S, Kwak L W, Jiang Y, Nattamai D, Lee S-T, Fowler D H, Sportes C, Gress R E, Steinberg S M, Vence L M, Radvanyi L, Dwyer K C, Qazilbash M H, Bryant R N K and Bishop M R. Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients. : Bone marrow transplantation. 20131211.